A Trial of Edaravone Dexborneol in Acute Ischemic Stroke With Active Malignancy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 144 participants.
Also called NCT07091994
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 144 participants
- Registry
-
NCT07091994
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07091994. Randomized; double masking; primary purpose treatment. Start 2026-08-01 (anticipated); primary completion 2026-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Trial of Edaravone Dexborneol in Acute Ischemic Stroke With Active Malignancy
- Acronym
- PRECISE AM
- Condition
- Ischemic Stroke, Acute
- Condition
- Active Malignancies
- Intervention (Drug)
- edaravone dexborneol injection
- Intervention (Drug)
- Standard therapeutic protocol
- Lead sponsor
- Nanfang Hospital, Southern Medical University
Record details
- Record id
cardio:ct-nct07091994- Content hash
a16c5353b0d4d261f0eb55f6257a797e7b5ba0f571c35d168e95425da9795e9f